CORD-19:dc97e1de3b69da13f534f15afdcedbf48064c69d / 638576-638753 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/dc97e1de3b69da13f534f15afdcedbf48064c69d","sourcedb":"CORD-19","sourceid":"dc97e1de3b69da13f534f15afdcedbf48064c69d","text":"Treatment of triazine exposure includes cardiovascular and renal support in the form of intravenous crystalloid fluids, inotropic drugs, and antiarrhythmic agents, as necessary.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T25215","span":{"begin":0,"end":177},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T25215","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T570","span":{"begin":0,"end":177},"obj":"Sentence"}],"attributes":[{"subj":"T570","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ecb293","default":true},{"id":"CORD-19_Custom_license_subset","color":"#9893ec"}]}]}}